A new report published by Newsinferno recently revealed that Johnson & Johnson marketed their Gynecare Prolift device for three years before the FDA approved its use. Johnson & Johnson introduced the vaginal mesh product into the market in 2005 without applying for FDA clearance. The product continued to be marketed, undetected by the FDA, until 2007 when Johnson & Johnson cited Gynecare Prolift as the predicate in the 510(k) application for a similar product, the Prolift + M. Neither mesh product was officially approved for market by the FDA until 2008.
Those involved with the mass tort cases against Johnson & Johnson believe that the unapproved marketing of the Gynecare Prolift device may increase the cost for Johnson & Johnson to resolve the lawsuits currently filed against them.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.